Endo International PLC (ENDP)

4.990
-0.290(-5.49%)
After Hours
4.920
-0.070(-1.403%)
- Real-time Data
  • Volume:
    4,031,038
  • Bid/Ask:
    4.850/4.920
  • Day's Range:
    4.860 - 5.330

ENDP Overview

Prev. Close
5.28
Day's Range
4.86-5.33
Revenue
2.96B
Open
5.31
52 wk Range
1.939-10.88
EPS
-0.01
Volume
4,031,038
Market Cap
1.17B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
10,060,775
P/E Ratio
176,000.00
Beta
1.19
1-Year Change
-8.61%
Shares Outstanding
233,670,998
Next Earnings Date
Mar 01, 2022
What is your sentiment on Endo International PLC?
or
Market is currently closed. Voting is open during market hours.

Endo International PLC Company Profile

Employees
3397

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren’s contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company’s Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company’s International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women’s health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellSellSellSell
Technical IndicatorsStrong BuyBuyStrong SellStrong SellNeutral
SummaryStrong BuyNeutralStrong SellStrong SellNeutral
  • yay
    0
    • 🚀
      0
      • This stock is a bargain buy, I used all the funds in my Roth IRA to buy close to 4,000 shares of ENDP two weeks ago. With patents on Chantix, expanding revenue, settlement of lawsuits, and a low P/E, the future for ENDP is bright. My price target is $200.
        0
        • fantastic outlook!
          0
      • 🎆🎆🎆🎆
        0
        • Everything is ok
          0
          • 🚀 🚀 🚀
            0
        • What's up with this stock?
          0
          • prepare for start 🚀
            0
        • ⏳🚀
          0
          • no bad news...
            0
            • Why down so much pre market
              0
          • Hopefully it will keep the momentum it had earlier
            0
            • 3.20 - best buy level...?
              0
              • 🌅🌅🌅😋
                0
                • Endo International Settles Louisiana Opioid Claimshttps://www.thestreet.com/investing/endo-international-settles-louisiana-opioid-claims🌅
                  0
                  • hopefully this will crash from premature hype
                    2
                    • wait for crush
                      0
                  • hopefully it will be 6+ within this month
                    0
                    • Buy and hold dont allow wall street to dictate sales and buys
                      0
                      • This is worth atleast $80! 🚀
                        0
                        • Need a little patience.
                          0
                      • blame dummies who dont have money to tolerate market loss and dump stocks
                        0
                        • This is just rising delay. Takeoff is coming
                          0
                      • It price should be 80+
                        0
                        • 80+ is ATH :) 20 is more realistic
                          0
                        • Hopefully it will cross 80 + near future
                          0
                      • let's go to the moon 🌙 7$
                        0
                        • ok
                          0
                      • Nice
                        0
                        • We are waiting for the trial, and tomorrow is Friday and everything will become clear. If it is true that they have settled everything, then there will be growth, but growth will go after the passengers are dropped because the paper is heavy and does not pull, although there is no volume. We are waiting for Monday, most likely, but tomorrow they can spill down, we must look.
                          1
                          • This company is a joke! Every rise is dumped! What a scam!!!
                            1
                            • what a scam!!!
                              3
                              • greetings everyone! any ideas on why such a fall today? were there any particular reasons for that or just a global market correction?
                                0
                                • Jasbir Dhillon looks like it's because of opioid crisis lawsuits...
                                  0
                                • kek pek most of them have been settled, and this is just pushing it. Pure price manipulation happening now.
                                  0
                                • kek pek and large sell-offs last week to follow red market
                                  0
                              • Airforce Exclusive Patent License! https://www.federalregister.gov/documents/2021/01/12/2021-00403/notice-of-intent-to-grant-an-exclusive-patent-license
                                0
                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.